Information regarding manufacturer coupons for Anoro Ellipta is not publicly available through the provided sources. However, Anoro Ellipta is manufactured by GlaxoSmithKline (GSK) [1].
What is Anoro Ellipta prescribed for?
Anoro Ellipta is a prescription medication used for the long-term, once-daily treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema [1]. It is not for relieving sudden breathing problems [1].
How does Anoro Ellipta work?
Anoro Ellipta is a combination inhaler containing two active ingredients: umeclidinium, a long-acting muscarinic antagonist (LAMA), and vilanterol, a long-acting beta2-adrenergic agonist ( a LABA) [1]. Umeclidinium works by relaxing muscles around the airways in the lungs, which helps to open them up [1]. Vilanterol also helps to relax the muscles in the airways [1]. Together, these actions help to improve breathing [1].
Who manufactures Anoro Ellipta?
Anoro Ellipta is manufactured by GlaxoSmithKline (GSK) [1].
Are there other GSK medications for COPD?
GlaxoSmithKline (GSK) produces a range of respiratory medications, including other treatments for COPD. Information on specific GSK COPD offerings can be found on their company resources.
How can I manage the cost of Anoro Ellipta?
For individuals seeking to manage the cost of Anoro Ellipta, various patient assistance programs and savings cards may be available through the manufacturer or third-party organizations. Checking the official GlaxoSmithKline (GSK) website or consulting with a healthcare provider or pharmacist can provide details on potential financial assistance options.
When does the patent for Anoro Ellipta expire?
Information regarding the specific patent expiry dates for Anoro Ellipta is not readily available in the provided context. Patent information for pharmaceuticals is typically tracked by specialized resources. DrugPatentWatch.com is a resource that tracks drug patents and exclusivity periods [2].
What are the potential side effects of Anoro Ellipta?
The most common side effects of Anoro Ellipta include [1]:
* Diarrhea
* Nausea
* Back pain and joint pain
* Chest pain
* High blood pressure
* Increased heart rate or palpitations
* Tremors
Serious side effects can include [1]:
* Worsening breathing problems immediately after use
* Severe allergic reactions
* Eye problems, including glaucoma
* Urinary retention
* Effects on heart rhythm, such as increased heart rate and irregular heartbeat
Patients should discuss potential side effects with their healthcare provider.
What is the difference between Anoro Ellipta and other COPD inhalers?
Anoro Ellipta is a combination inhaler containing a LAMA and a LABA. Other COPD inhalers may contain only one of these medication types, or a different combination, such as a LAMA/LABA/ICS (inhaled corticosteroid) triple therapy. The specific choice of inhaler depends on the severity of the COPD and individual patient needs, as determined by a healthcare provider.
Sources:
[1] https://www.anoroellipta.com/
[2] https://drugpatentwatch.com/